PZU SA:企業の戦略・SWOT・財務情報

◆英語タイトル:PZU SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3993
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ポーランド
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

PZU SA – Strategy, SWOT and Corporate Finance Report
Summary

PZU SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

PZU SA (PZU), a subsidiary of PZU Capital Group, is a multi-line insurance company. The company offers a range of life and non-life insurance products and services to individuals, families and corporate customers. The insurance products offered by the company include property insurance, life insurance, personal accident insurance, home insurance, and compulsory insurance. It also offers investment services including pension fund, investment funds, and savings programs. PZU offers comprehensive insurance coverage in all key sectors of private, public, and economic activity. It also offers health care insurance services. The company distributes its products through a network of multi-agencies, insurance brokers, bancassurance and strategic partnership programs, branch offices, and exclusive agents. The company has operation in the US, Canada, Poland, the UK, Germany, France, Netherlands, Norway, Switzerland, Singapore, China, Japan and Hong Kong. PZU is headquartered in Warsaw, Poland.

The company reported gross written premiums of PLN20,219 million during fiscal year ended December 2016 (FY2016), an increase of 10.1% over FY2015. Its net premiums earned was PLN18,625 million, an increase of 7.1% over FY2015.

Scope

- Detailed information on PZU SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting PZU SA in the form of a SWOT analysis
- An in-depth view of the business model of PZU SA including a breakdown and examination of key business segments
- Intelligence on PZU SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about PZU SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of PZU SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess PZU SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on PZU SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
PZU SA: Company Overview 9
PZU SA: Overview and Key Facts 9
PZU SA: Overview 9
PZU SA: Key Facts 9
PZU SA: Key Employees 11
PZU SA: Key Employee Biographies 12
PZU SA: Major Products and Services 13
PZU SA: Company History 14
PZU SA: Management Statement 16
PZU SA: Company Analysis 18
PZU SA: Business Description 18
PZU SA: SWOT Analysis 20
PZU SA: SWOT Overview 20
PZU SA: Strengths 20
PZU SA: Weaknesses 21
PZU SA: Opportunities 21
PZU SA: Threats 21
PZU SA: Corporate Financial Deals Activity 23
PZU SA: Financial Deals Overview 23
PZU SA: Top Deals 2014 – 2018YTD* 24
PZU SA: Advisors 25
PZU SA: Top Legal Advisors 25
PZU SA: Mergers and Acquisitions 26
PZU SA: Recent Developments 27
PZU SA: News and Events Summary 27
PZU SA: Corporate Governance 28
PZU SA: Red Flags/DistressSignals 30
Appendix 32
Contact Us 32
Methodology 32
About MarketLine 33

List of Tables
Table 1: PZU SA: Key Facts
Table 2: PZU SA: Key Employees
Table 3: PZU SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 4: PZU SA: M&A Average Deal Size - Value (US$m)
Table 5: PZU SA: Top Deals 2014 - 2018YTD*
Table 6: PZU SA: Legal Advisor Ranking by Value (US$m)
Table 7: PZU SA: M&A Volume and Value Trend (2014 - YTD*2018)
Table 8: PZU SA: News and Events Summary
Table 9: PZU SA: Corporate Governance
Table 10: PZU SA: Red Flags/DistressSignals

List of Figures
Figure 1: PZU SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: PZU SA: M&A Average Deal Size - Value (US$m)
Figure 3: PZU SA: M&A Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[PZU SA:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VWR International LLC-製薬・医療分野:企業M&A・提携分析
    Summary VWR International LLC (VWR) a subsidiary of VWR Corp is a supplier of products, services and solutions to laboratories. The company’s business areas comprise differentiated services, product choice and operational excellence. Its product choice services include supply of beakers, freezers, b …
  • Circassia Pharmaceuticals Plc (CIR):製薬・医療:M&Aディール及び事業提携情報
    Summary Circassia Pharmaceuticals plc (Circassia) develops and manufactures drugs for the treatment of allergy and respiratory diseases such as asthma. The company’s marketed products include Niox used to assist asthma management and Tudorza for the treatment of chronic obstructive pulmonary disease …
  • Astrazeneca Pharma India Ltd (ASTRAZEN):企業の財務・戦略的SWOT分析
    Summary AstraZeneca Pharma India Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc, is a biopharmaceutical company. It discovers, develops, supplies and commercializes medicines. The company’s product portfolio include Forxiga, Imdur, Crestor, Tagrisso, Lynparza, Betaloc, Symbicort, budesonide, for …
  • Midatech Pharma US Inc-製薬・医療分野:企業M&A・提携分析
    Summary Midatech Pharma US Inc (Midatech Pharma), formerly DARA BioSciences, Inc., is a pharmaceutical company which focuses on the development and commercialization of cancer treatment and supportive care products. The company’s product portfolio includes Soltamox for the treatment and prevention o …
  • NFP Corp.:企業のM&A・事業提携・投資動向
    NFP Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NFP Corp. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Dr. Ci:Labo Co., Ltd.:企業の戦略・SWOT・財務情報
    Dr. Ci:Labo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dr. Ci:Labo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ormat Technologies Inc (ORA):企業の財務・戦略的SWOT分析
    Ormat Technologies Inc (ORA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Avon Products, Inc.:企業の戦略・SWOT・財務情報
    Avon Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Avon Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Pfizer Inc (PFE)-製薬・医療分野:企業M&A・提携分析
    Summary Pfizer Inc (Pfizer) is a biopharmaceutical company, which discovers, develops, manufactures and markets healthcare products. It provides medicines, vaccines and consumer healthcare products. The company provides products to treat various conditions including infection, cancer, inflammation, …
  • MTF Biologics:医療機器:M&Aディール及び事業提携情報
    Summary MTF Biologics(MTF) formerly known as Musculoskeletal Transplant Foundation, is a subsidiary of Donor Network West is a medical foundation that offers clinically sound and safe allograft tissue. The foundation offers allograft bone, sports tissue and dermal tissues. Its products include morse …
  • Lannett Company Inc (LCI):企業の財務・戦略的SWOT分析
    Lannett Company Inc (LCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Aston Martin Lagonda Global Holdings Plc (AML):企業の財務・戦略的SWOT分析
    Aston Martin Lagonda Global Holdings Plc (AML) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Kongsberg Maritime AS:企業の戦略的SWOT分析
    Kongsberg Maritime AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Biogened SA-製薬・医療分野:企業M&A・提携分析
    Summary BIOGENED SA (Biogened) is a drug company that develops, produces, and distributes Rx medicines and dietary supplements. The company’s products include recipes dermocosmetic products, specialized products, active ingredients, pharmaceutical products, and cosmetic products. Its also offers nov …
  • Sino Gas & Energy Holdings Ltd (SEH):企業の財務・戦略的SWOT分析
    Summary Sino Gas & Energy Holdings Ltd (Sino Gas), a subsidiary of MIE Holdings Corp, is an oil and gas company that explores and develops unconventional gas assets production sharing contracts. The company holds working interest in the Linxing PSC and the Sanjiaobei PSC projects. It has strategic A …
  • Illinois Tool Works Inc.:企業のM&A・事業提携・投資動向
    Illinois Tool Works Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Illinois Tool Works Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Confused.Com Limited
    Confused.Com Limited - Strategy, SWOT and Corporate Finance Report Summary Confused.Com Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • J.M. Huber Corp:企業の戦略的SWOT分析
    J.M. Huber Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Lycamobile UK Limited:企業の戦略的SWOT分析
    Lycamobile UK Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • S&P Global Inc (SPGI):企業の財務・戦略的SWOT分析
    S&P Global Inc (SPGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆